Journal for ImmunoTherapy of Cancer (Oct 2021)
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Oct 2021)